The role of maintenance therapy in patients with diffuse large B cell lymphoma: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

The role of maintenance therapy in patients with diffuse large B cell lymphoma: A systematic review and meta‐analysis

Published:2018-10-08 Issue:1 Volume:37 Page:27-34
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Rozental Alon¹²^ORCID,Gafter‐Gvili Anat³²,Vidal Liat¹²^ORCID,Raanani Pia¹²,Gurion Ronit¹²

Affiliation:

1. Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center Petah Tikva Israel

2. Sackler Faculty of MedicineTel Aviv University Tel Aviv Israel

3. Department of Internal Medicine ARabin Medical Center Petah Tikva Israel

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2561

Reference34 articles.

1. State-of-the-Art Therapeutics: Diffuse Large B-Cell Lymphoma

2. Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

3. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

4. Improving survival and preventing recurrence of diffuse large B‐cell lymphoma in younger patients: current strategies and future directions;Karlin L;Onco Targets Ther,2013

5. Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Evolution of therapy for limited stage diffuse large B-cell lymphoma;Blood Cancer Journal;2022-02-24

3. Substanzen gegen molekulare Zielstrukturen;Springer Reference Medizin;2022

4. R-CHOP compared to R-CHOP + X for newly diagnosed diffuse large B-cell lymphoma: a systematic review and meta-analysis;Acta Oncologica;2021-03-18

5. Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma;Therapeutic Advances in Hematology;2021-01